Melvin H. Hayes Iii.
Chief Operating Officer, Fulcrum Therapeutics (United States).
Companies
- Fulcrum Therapeutics (United States)Chief operating officer Aug 11, 2022 to Apr 28, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Fulcrum Therapeutics (United States) FULC0 shares2Aug 11, 2022
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2